nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—SLC22A7—Glyburide—gestational diabetes	0.519	0.702	CbGbCtD
Minocycline—SLC22A6—Glyburide—gestational diabetes	0.221	0.298	CbGbCtD
Minocycline—MMP9—tunica intima—gestational diabetes	0.0285	0.172	CbGeAlD
Minocycline—CYCS—islet of Langerhans—gestational diabetes	0.00823	0.0497	CbGeAlD
Minocycline—CYCS—embryo—gestational diabetes	0.00796	0.048	CbGeAlD
Minocycline—CASP3—islet of Langerhans—gestational diabetes	0.00705	0.0425	CbGeAlD
Minocycline—CASP3—embryo—gestational diabetes	0.00681	0.0411	CbGeAlD
Minocycline—IL1B—islet of Langerhans—gestational diabetes	0.00563	0.034	CbGeAlD
Minocycline—CASP1—uterus—gestational diabetes	0.00557	0.0336	CbGeAlD
Minocycline—VEGFA—islet of Langerhans—gestational diabetes	0.00554	0.0334	CbGeAlD
Minocycline—CASP1—adipose tissue—gestational diabetes	0.00545	0.0329	CbGeAlD
Minocycline—IL1B—embryo—gestational diabetes	0.00544	0.0329	CbGeAlD
Minocycline—CYCS—uterus—gestational diabetes	0.00536	0.0324	CbGeAlD
Minocycline—CASP3—uterus—gestational diabetes	0.0046	0.0277	CbGeAlD
Minocycline—MMP9—embryo—gestational diabetes	0.00454	0.0274	CbGeAlD
Minocycline—CASP1—vagina—gestational diabetes	0.00453	0.0273	CbGeAlD
Minocycline—CASP3—adipose tissue—gestational diabetes	0.00449	0.0271	CbGeAlD
Minocycline—CASP1—head—gestational diabetes	0.00419	0.0253	CbGeAlD
Minocycline—CYCS—head—gestational diabetes	0.00403	0.0243	CbGeAlD
Minocycline—CASP3—vagina—gestational diabetes	0.00374	0.0225	CbGeAlD
Minocycline—ALOX5—islet of Langerhans—gestational diabetes	0.00371	0.0224	CbGeAlD
Minocycline—IL1B—uterus—gestational diabetes	0.00367	0.0222	CbGeAlD
Minocycline—VEGFA—uterus—gestational diabetes	0.00361	0.0218	CbGeAlD
Minocycline—IL1B—adipose tissue—gestational diabetes	0.00359	0.0217	CbGeAlD
Minocycline—IL1B—Leptin signaling pathway—LEPR—gestational diabetes	0.00359	0.0379	CbGpPWpGaD
Minocycline—VEGFA—adipose tissue—gestational diabetes	0.00353	0.0213	CbGeAlD
Minocycline—CASP3—head—gestational diabetes	0.00345	0.0208	CbGeAlD
Minocycline—MMP9—uterus—gestational diabetes	0.00306	0.0185	CbGeAlD
Minocycline—MMP9—adipose tissue—gestational diabetes	0.00299	0.0181	CbGeAlD
Minocycline—IL1B—vagina—gestational diabetes	0.00298	0.018	CbGeAlD
Minocycline—VEGFA—vagina—gestational diabetes	0.00294	0.0177	CbGeAlD
Minocycline—IL1B—head—gestational diabetes	0.00276	0.0166	CbGeAlD
Minocycline—CASP1—Cellular roles of Anthrax toxin—TNF—gestational diabetes	0.00249	0.0263	CbGpPWpGaD
Minocycline—ALOX5—adipose tissue—gestational diabetes	0.00237	0.0143	CbGeAlD
Minocycline—MMP9—head—gestational diabetes	0.0023	0.0139	CbGeAlD
Minocycline—CASP1—MAPK Signaling Pathway—GCK—gestational diabetes	0.00207	0.0218	CbGpPWpGaD
Minocycline—MMP9—Angiogenesis—FGF2—gestational diabetes	0.00183	0.0193	CbGpPWpGaD
Minocycline—ALOX5—head—gestational diabetes	0.00182	0.011	CbGeAlD
Minocycline—VEGFA—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.00182	0.0192	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—MBL2—gestational diabetes	0.00167	0.0177	CbGpPWpGaD
Minocycline—CASP1—Amyotrophic lateral sclerosis (ALS)—TNF—gestational diabetes	0.00161	0.017	CbGpPWpGaD
Minocycline—VEGFA—Angiogenesis—FGF2—gestational diabetes	0.00159	0.0167	CbGpPWpGaD
Minocycline—IL1B—Cellular roles of Anthrax toxin—TNF—gestational diabetes	0.00155	0.0164	CbGpPWpGaD
Minocycline—CYCS—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—gestational diabetes	0.00154	0.0163	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.00151	0.016	CbGpPWpGaD
Minocycline—VEGFA—Glypican 1 network—FGF2—gestational diabetes	0.00149	0.0157	CbGpPWpGaD
Minocycline—MMP9—Syndecan-4-mediated signaling events—FGF2—gestational diabetes	0.00145	0.0153	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—GCK—gestational diabetes	0.00143	0.0151	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.00137	0.0145	CbGpPWpGaD
Minocycline—IL1B—IL27-mediated signaling events—TNF—gestational diabetes	0.00136	0.0144	CbGpPWpGaD
Minocycline—IL1B—Cytokines and Inflammatory Response—TNF—gestational diabetes	0.00132	0.0139	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—GCK—gestational diabetes	0.00129	0.0136	CbGpPWpGaD
Minocycline—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—AR—gestational diabetes	0.00128	0.0135	CbGpPWpGaD
Minocycline—CYCS—FAS pathway and Stress induction of HSP regulation—TNF—gestational diabetes	0.00127	0.0134	CbGpPWpGaD
Minocycline—IL1B—Leptin signaling pathway—LEP—gestational diabetes	0.00126	0.0133	CbGpPWpGaD
Minocycline—CASP3—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—gestational diabetes	0.00124	0.0131	CbGpPWpGaD
Minocycline—SLC22A8—head—gestational diabetes	0.00123	0.00742	CbGeAlD
Minocycline—IL1B—Monoamine Transport—TNF—gestational diabetes	0.00115	0.0122	CbGpPWpGaD
Minocycline—CYCS—Ceramide signaling pathway—TNF—gestational diabetes	0.00114	0.012	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	0.00114	0.012	CbGpPWpGaD
Minocycline—CASP3—Amyotrophic lateral sclerosis (ALS)—TNF—gestational diabetes	0.00111	0.0117	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—AR—gestational diabetes	0.00111	0.0117	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—AR—gestational diabetes	0.00108	0.0114	CbGpPWpGaD
Minocycline—IL1B—IL23-mediated signaling events—TNF—gestational diabetes	0.00103	0.0108	CbGpPWpGaD
Minocycline—CASP3—FAS pathway and Stress induction of HSP regulation—TNF—gestational diabetes	0.00102	0.0108	CbGpPWpGaD
Minocycline—CASP3—TWEAK Signaling Pathway—TNF—gestational diabetes	0.00102	0.0108	CbGpPWpGaD
Minocycline—CYCS—Caspase Cascade in Apoptosis—TNF—gestational diabetes	0.000994	0.0105	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—AR—gestational diabetes	0.000975	0.0103	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—LEP—gestational diabetes	0.000969	0.0102	CbGpPWpGaD
Minocycline—MMP9—Matrix Metalloproteinases—TNF—gestational diabetes	0.00093	0.00983	CbGpPWpGaD
Minocycline—VEGFA—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.000929	0.00981	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000916	0.00968	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.000913	0.00964	CbGpPWpGaD
Minocycline—VEGFA—Differentiation Pathway—FGF2—gestational diabetes	0.000911	0.00962	CbGpPWpGaD
Minocycline—CASP3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—gestational diabetes	0.000891	0.00941	CbGpPWpGaD
Minocycline—MMP9—amb2 Integrin signaling—TNF—gestational diabetes	0.000883	0.00933	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—LEP—gestational diabetes	0.000877	0.00926	CbGpPWpGaD
Minocycline—IL1B—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000862	0.0091	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—MBL2—gestational diabetes	0.000857	0.00905	CbGpPWpGaD
Minocycline—CASP1—Apoptosis—TNF—gestational diabetes	0.000852	0.009	CbGpPWpGaD
Minocycline—MMP9—Endochondral Ossification—FGF2—gestational diabetes	0.000833	0.0088	CbGpPWpGaD
Minocycline—CASP3—Caspase Cascade in Apoptosis—TNF—gestational diabetes	0.000802	0.00847	CbGpPWpGaD
Minocycline—IL1B—Vitamin B12 Metabolism—TNF—gestational diabetes	0.000793	0.00838	CbGpPWpGaD
Minocycline—CYCS—Alzheimers Disease—TNF—gestational diabetes	0.000765	0.00809	CbGpPWpGaD
Minocycline—VEGFA—Integrins in angiogenesis—FGF2—gestational diabetes	0.000733	0.00774	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TNF—gestational diabetes	0.000729	0.0077	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—FGF2—gestational diabetes	0.000723	0.00764	CbGpPWpGaD
Minocycline—MMP9—TWEAK Signaling Pathway—TNF—gestational diabetes	0.000711	0.00751	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	0.000685	0.00724	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—LEP—gestational diabetes	0.000672	0.0071	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—AR—gestational diabetes	0.000666	0.00704	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—AR—gestational diabetes	0.000649	0.00686	CbGpPWpGaD
Minocycline—SLC22A11—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000647	0.00683	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—TNF—gestational diabetes	0.000645	0.00682	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000634	0.0067	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GGCT—gestational diabetes	0.000624	0.00659	CbGpPWpGaD
Minocycline—CASP3—Alzheimers Disease—TNF—gestational diabetes	0.000618	0.00652	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—TNF—gestational diabetes	0.000618	0.00652	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TNF—gestational diabetes	0.000588	0.00621	CbGpPWpGaD
Minocycline—SLC22A7—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000587	0.0062	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000574	0.00606	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—TNF—gestational diabetes	0.000559	0.00591	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—TNF—gestational diabetes	0.000559	0.00591	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000552	0.00583	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—TNF—gestational diabetes	0.000547	0.00578	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GLS2—gestational diabetes	0.000545	0.00576	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—TNF—gestational diabetes	0.000513	0.00542	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000501	0.00529	CbGpPWpGaD
Minocycline—CASP1—Immune System—MBL2—gestational diabetes	0.000499	0.00527	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000493	0.00521	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TNF—gestational diabetes	0.000489	0.00517	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—TNF—gestational diabetes	0.000456	0.00481	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TNF—gestational diabetes	0.000448	0.00473	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TNF—gestational diabetes	0.000446	0.00472	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—FGF2—gestational diabetes	0.000443	0.00468	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—TNF—gestational diabetes	0.000433	0.00457	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—GCK—gestational diabetes	0.000418	0.00442	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000412	0.00435	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TNF—gestational diabetes	0.000406	0.00428	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—FGF2—gestational diabetes	0.000386	0.00408	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GGCT—gestational diabetes	0.000384	0.00406	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—TNF—gestational diabetes	0.000372	0.00393	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—GCK—gestational diabetes	0.000363	0.00383	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—FGF2—gestational diabetes	0.000362	0.00383	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TNF—gestational diabetes	0.00036	0.00381	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—TNF—gestational diabetes	0.000358	0.00379	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—TNF—gestational diabetes	0.000356	0.00376	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—ADIPOQ—gestational diabetes	0.000344	0.00364	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TNF—gestational diabetes	0.000338	0.00357	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GLS2—gestational diabetes	0.000336	0.00355	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000329	0.00347	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—TNF—gestational diabetes	0.000324	0.00343	CbGpPWpGaD
Minocycline—IL1B—Immune System—MBL2—gestational diabetes	0.000312	0.0033	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TNF—gestational diabetes	0.000311	0.00329	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TNF—gestational diabetes	0.000306	0.00323	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000305	0.00322	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000302	0.00319	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.0003	0.00317	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—FGF2—gestational diabetes	0.000299	0.00316	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—ADIPOQ—gestational diabetes	0.000299	0.00316	CbGpPWpGaD
Minocycline—CYCS—Metabolism—NAMPT—gestational diabetes	0.000299	0.00316	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000298	0.00315	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GCK—gestational diabetes	0.000297	0.00314	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—LEPR—gestational diabetes	0.000292	0.00308	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—FGF2—gestational diabetes	0.000268	0.00283	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000251	0.00265	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MTNR1B—gestational diabetes	0.000231	0.00244	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RBP4—gestational diabetes	0.000225	0.00237	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CYP19A1—gestational diabetes	0.000217	0.00229	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—TNF—gestational diabetes	0.000216	0.00228	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—LEP—gestational diabetes	0.000214	0.00226	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000209	0.00221	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LEPR—gestational diabetes	0.000203	0.00214	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—LEP—gestational diabetes	0.000186	0.00196	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NAMPT—gestational diabetes	0.000184	0.00194	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000184	0.00194	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GCK—gestational diabetes	0.000183	0.00193	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LEPR—gestational diabetes	0.000176	0.00186	CbGpPWpGaD
Minocycline—CASP1—Immune System—FGF2—gestational diabetes	0.000174	0.00184	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—FGF2—gestational diabetes	0.000162	0.00172	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MTNR1B—gestational diabetes	0.00016	0.00169	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RBP4—gestational diabetes	0.000156	0.00165	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—FGF2—gestational diabetes	0.000141	0.00149	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MTNR1B—gestational diabetes	0.000139	0.00147	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RBP4—gestational diabetes	0.000135	0.00143	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP19A1—gestational diabetes	0.000134	0.00141	CbGpPWpGaD
Minocycline—IL1B—Immune System—FGF2—gestational diabetes	0.000109	0.00115	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—LEP—gestational diabetes	0.000102	0.00108	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TNF—gestational diabetes	9.89e-05	0.00105	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TNF—gestational diabetes	8.59e-05	0.000907	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGF2—gestational diabetes	7.78e-05	0.000822	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LEP—gestational diabetes	7.11e-05	0.000751	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LEP—gestational diabetes	6.17e-05	0.000652	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGF2—gestational diabetes	5.4e-05	0.000571	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGF2—gestational diabetes	4.69e-05	0.000495	CbGpPWpGaD
